Clinical Trials on Central Sleep Apnea, Secondary in Czechia

Total 68 results

St. Anne's University Hospital Brno, Czech Republic

Completed

Influence of Different Anesthetic Procedures on Sleep Disorder Breathing

Obstructive Sleep Apnea

Czechia
University Hospital Ostrava

Completed

Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea

Sleep-Disordered Breathing | Obstructive Sleep Apnoea

Czechia
St. Anne's University Hospital Brno, Czech Republic
Masaryk University

Recruiting

OSA as a Remote Ischemic Preconditioning in Vascular Surgery

Obstructive Sleep Apnea | Ischemia Reperfusion Injury | Vascular Aneurysm

Czechia
Brno University Hospital

Recruiting

Obstructive Sleep Apnea and Comprehensive Remotely-supervised Rehabilitation Program

Obstructive Sleep Apnea

Czechia
University Hospital Olomouc

Recruiting

The Effect of CPAP Treatment on Cognitive Functions, Anxiety, and Affective Symptoms

Obstructive Sleep Apnea

Czechia
University Hospital Olomouc

Completed

The Effect of CPAP on Lung Hyperinflation in Patients With OSA

Obstructive Sleep Apnea

Czechia
St. Anne's University Hospital Brno, Czech Republic

Completed

Relationship Between Normal-weight Central Obesity and Obstructive Sleep Apnea

Sleep Disorder | Body Fat Distribution

Czechia
Faculty Hospital Kralovske Vinohrady

Recruiting

Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome (NORRIS)

Obesity | Obstructive Sleep Apnea

Czechia
Faculty Hospital Kralovske Vinohrady

Completed

Fatty Acid Metabolism in Obstructive Sleep Apnea (FAMOSA) (FAMOSA)

Obstructive Sleep Apnea | Continuous Positive Airway Pressure | Fatty Acid Metabolism

Czechia
University Hospital Olomouc

Completed

Masked Hypertension in Patients With Obstructive Sleep Apnoea

Obstructive Sleep Apnea

Czechia
University Hospital, Motol

Recruiting

Obstructive Sleep Apnea Management in People With Spinal Cord Injury

Obstructive Sleep Apnea | Spinal Cord Injuries

Czechia
University Hospital Ostrava

Recruiting

This Research Project Studies the Relationship Between OSA and Nocturia.

Obstructive Sleep Apnea

Czechia
Charles University, Czech Republic

Completed

Combined RF Surgery of the Tongue Base and Uvulopalatopharyngoplasty (UPPP) for Obstructive Sleep Apnea

Sleep Apnea Syndrome

Czech Republic
Aspire Medical

Completed

Tongue Advancement for Obstructive Sleep Apnea

Sleep Apnea, Obstructive

Belgium, Czech Republic, Germany
University Hospital Ostrava

Completed

Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy

Snoring | Otitis | Hearing Loss | Nasal Obstruction | Apnea, Obstructive | Nasopharyngeal Obstruction

Czechia
Revent Medical International B.V.
Revent Medical, Inc.

Terminated

REV 002 Observational Study of the ReVENT Sleep Apnea System: Minimally Invasive Treatment for Obstructive Sleep Apnea

Obstructive Sleep Apnea

Germany, Belgium, Netherlands, Czech Republic, Switzerland
Technische Universität Dresden

Unknown

Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea (Reverse-STEAL)

Ischemic Stroke

United States, Austria, Czech Republic, Germany
Eli Lilly and Company

Completed

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea (SURMOUNT-OSA)

Obesity | Sleep Apnea

United States, China, Taiwan, Germany, Mexico, Brazil, Japan, Czechia, Australia, Puerto Rico
ResMed
CRI-The Clinical Research Institute GmbH

Completed

Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure (Serve-HF)

Heart Failure | Sleep Disordered Breathing

Germany, Netherlands, Australia, Denmark, France, United Kingdom, Switzerland, Norway, Finland, Sweden, Czechia
Jan Malecek

Completed

Can Ammonium Inhalants Maintain Performance in Sleep Deprived Soldiers?

Sleep | Cognitive Change | Sleep Deprivation | Military Activity | Military Combat Stress Reaction

Czechia
Czech Technical University in Prague

Recruiting

Plethysmography Curve Variability Depending on the Breath Cycle

Apnea | Respiration | Circulatory; Change

Czechia
University of Ostrava
University Hospital Ostrava; General University Hospital, Prague

Recruiting

Sleep Disturbances and Delirium (SLEEP)

Sleep Disturbance

Czechia
Amgen

Recruiting

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Spain, Belgium, Germany, Czechia, Poland, France, Greece, Hungary, Italy, United Kingdom, Lithuania, Portugal
Czech Technical University in Prague
Mayo Clinic; University Hospital, Montpellier; McGill University Health Centre... and other collaborators

Unknown

Detecting Parkinson's Disease Through Speech Analysis

Parkinson Disease | REM Sleep Behavior Disorder

United States, Canada, Austria, Czechia, France, Germany, Italy
Amgen

Completed

Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis

Secondary Hyperparathyroidism, Chronic Kidney Disease

United States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
Amgen

Terminated

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Chronic Kidney Disease, Secondary Hyperparathyroidism

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia (GEMS)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Canada, Australia, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Chile
Boehringer Ingelheim

Completed

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Venous Thromboembolism | Secondary Prevention

United States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year (EPLILONG)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Austria, Finland, Chile, Canada, Australia
AbbVie (prior sponsor, Abbott)

Completed

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Bulgaria, Czech Republic, Romania
Bayer

Recruiting

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause (NIRVANA)

Sleep Disturbances Associated With Menopause

United States, Germany, Belgium, Czechia, Poland, Austria, Spain, Netherlands
Jazz Pharmaceuticals

Completed

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Narcolepsy With Cataplexy

Belgium, United States, Spain, Czechia, France, Finland
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Insomnia Disorder

United States, Korea, Republic of, Germany, Belgium, Bulgaria, Canada, Czechia, Finland, France, Hungary, Sweden
Antisoma Research

Unknown

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
Takeda

Recruiting

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Multiple Myeloma | Secondary Immunodeficiency (SID)

Greece, Spain, Italy, Romania, Argentina, Czechia, France, Germany, Poland, Sweden, Turkey
Abbott

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D (IMPACT SHPT)

Hemodialysis | Chronic Kidney Disease | Secondary Hyperparathyroidism

United States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
Amgen

Completed

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease (BONAFIDE)

Secondary Hyperparathyroidism

United States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
Biogen

Terminated

BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis (INSPIRE)

Multiple Sclerosis, Secondary Progressive

United States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
Takeda

Completed

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

Chronic Insomnia

United States, Australia, France, Germany, Belgium, Finland, Russian Federation, Italy, Czech Republic
Amgen

Completed

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
Jazz Pharmaceuticals

Recruiting

A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Narcolepsy

United States, Belgium, Spain, France, Italy, Czechia
Midnight Pharma, LLC

Completed

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia (RESTORA 1)

Primary Insomnia

Spain, Germany, Belgium, France, United Kingdom, Australia, Austria, Bulgaria, Czech Republic, Denmark, Finland, Hungary, Israel, Italy, Poland, Slovakia, South Africa, Sweden, Switzerland, Ukraine
Amgen

Terminated

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Chronic Kidney Disease | Hyperparathyroidism, Secondary

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
UCB Pharma

Completed

Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Narcolepsy

Austria, Belgium, Czech Republic, Germany, Ireland, Italy, Spain, Switzerland, United Kingdom
Jazz Pharmaceuticals

Completed

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

Idiopathic Hypersomnia

France, Spain, United States, Belgium, United Kingdom, Poland, Czechia, Finland
Theranexus

Completed

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

Parkinson Disease

United States, France, Czechia, Germany, Hungary
Apellis Pharmaceuticals, Inc.

Active, not recruiting

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (GALE)

Geographic Atrophy Secondary to Age-related Macular Degeneration

United States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
Sanofi

Completed

Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus (SAMS12)

Sleep Initiation and Maintenance Disorders

United States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
Avadel

Completed

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Narcolepsy | Cataplexy | Excessive Daytime Sleepiness

United States, Germany, Australia, Canada, Czechia, France

Clinical Trials on Central Sleep Apnea, Secondary in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations